{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T02:06:54Z","timestamp":1649038014622},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1093\/qjmed\/hch033","type":"journal-article","created":{"date-parts":[[2004,2,19]],"date-time":"2004-02-19T17:37:57Z","timestamp":1077212277000},"page":"179-180","source":"Crossref","is-referenced-by-count":2,"title":["Controlling persistent atrial fibrillation"],"prefix":"10.1093","volume":"97","author":[{"given":"R.J.","family":"Shelton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.C.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.G.F.","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,3]]},"reference":[{"key":"key\n\t\t\t\t20170413035531_BIB1","doi-asserted-by":"crossref","unstructured":"Boos CJ, Carlsson J, More RS. Rate or rhythm control in persistent atrial fibrillation. Q J Med2003; 96:881\u201392.","DOI":"10.1093\/qjmed\/hcg147"},{"key":"key\n\t\t\t\t20170413035531_BIB2","doi-asserted-by":"crossref","unstructured":"Khand AU, Rankin AC, Kaye GC, Cleland JGF. Systematic review of the management of atrial fibrillation in patients with heart failure. Eur Heart J 2000; 21:614\u201332.","DOI":"10.1053\/euhj.1999.1767"},{"key":"key\n\t\t\t\t20170413035531_BIB3","doi-asserted-by":"crossref","unstructured":"Cleland JG, Chattopadhyay S, Khand A, Houghton T, Kaye GC. Prevalence and incidence of arrhythmias and sudden death in heart failure. Heart Fail Rev2002;7:229\u201342","DOI":"10.1023\/A:1020024122726"},{"key":"key\n\t\t\t\t20170413035531_BIB4","doi-asserted-by":"crossref","unstructured":"Task Force for the Diagnosis and Treatment of Chronic Heart Failure ESoC, Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J2001; 22:1527\u201360","DOI":"10.1053\/euhj.2001.2783"},{"key":"key\n\t\t\t\t20170413035531_BIB5","doi-asserted-by":"crossref","unstructured":"Cowburn PJ, Cleland JGF, Coats AJS, Komajda M. Risk stratification in chronic heart failure. Eur Heart J1998; 19:696\u2013710.","DOI":"10.1053\/euhj.1997.0820"},{"key":"key\n\t\t\t\t20170413035531_BIB6","doi-asserted-by":"crossref","unstructured":"Benjamin EJ, Levy D, Vaziri SM, D\u2019Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-base cohort: the Framingham Heart Study. JAMA1994; 271:840\u20134.","DOI":"10.1001\/jama.1994.03510350050036"},{"key":"key\n\t\t\t\t20170413035531_BIB7","doi-asserted-by":"crossref","unstructured":"Middlekauf HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation and advanced heart failure. A study of 390 patients. Circulation1991; 84:40\u20138.","DOI":"10.1161\/01.CIR.84.1.40"},{"key":"key\n\t\t\t\t20170413035531_BIB8","doi-asserted-by":"crossref","unstructured":"Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol1998; 32:695\u2013703.","DOI":"10.1016\/S0735-1097(98)00297-6"},{"key":"key\n\t\t\t\t20170413035531_BIB9","unstructured":"Wozakowska-Kaplon B, Opoloski G. Improvement in exercise performance after successful cardioversion in patients with persistent atrial fibrillation and symptoms of heart failure. Kardiol Pol2003; 59:213\u201323."},{"key":"key\n\t\t\t\t20170413035531_BIB10","doi-asserted-by":"crossref","unstructured":"Gosselink AT, Crijns HJ, van der Berg MP, et al. Functional capacity before and after cardioversion of atrial fibrillation: a controlled study. Br Heart J1994; 72:161\u20136.","DOI":"10.1136\/hrt.72.2.161"},{"key":"key\n\t\t\t\t20170413035531_BIB11","doi-asserted-by":"crossref","unstructured":"Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation1999; 100:376\u201380.","DOI":"10.1161\/01.CIR.100.4.376"},{"key":"key\n\t\t\t\t20170413035531_BIB12","doi-asserted-by":"crossref","unstructured":"Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, Ducharme A. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation2003; 107:2926\u201331","DOI":"10.1161\/01.CIR.0000072793.81076.D4"},{"key":"key\n\t\t\t\t20170413035531_BIB13","unstructured":"McMurray JJV, Dargie HJ, Ford I, Lopez-Sendon JL, Remme WJ, Sharpe N, Blank A, Staiger C. Carvedilol reduces supraventricular and ventricular arrhythmias after myocardial infarction: evidence from the CAPRICORN study. Circulation2001; 104(suppl. II):II\u2013700."},{"key":"key\n\t\t\t\t20170413035531_BIB14","doi-asserted-by":"crossref","unstructured":"Madrid AH, Bueno MG, Rebollo JMG, et al. Use of Irbesartan to maintain sinus rhythm in patients with long-asting persistent atrial fibraillation. Circulation2002; 106:331\u20136.","DOI":"10.1161\/01.CIR.0000022665.18619.83"},{"key":"key\n\t\t\t\t20170413035531_BIB15","doi-asserted-by":"crossref","unstructured":"Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K. Angiotensin II antagonist prevents electrical remodelling in atrial fibrillation. Circulation2000; 101:2612\u201317.","DOI":"10.1161\/01.CIR.101.22.2612"},{"key":"key\n\t\t\t\t20170413035531_BIB16","doi-asserted-by":"crossref","unstructured":"Khand A, Cleland J.G.F., Deedwania P. Prevention of and Medical Therapy for Atrial Arrhythmias in Heart Failure. Heart Fail Rev2002; 7:267\u201383.","DOI":"10.1023\/A:1020097728178"},{"key":"key\n\t\t\t\t20170413035531_BIB17","doi-asserted-by":"crossref","unstructured":"Tieleman RG, Gosselink AT, Crijns HJ, van Gelder IC, van den Berg MP, de Kam PJ, van Gilst WH, Lie KI. Efficacy, safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone. Am J Cardiol1997; 79:53\u20137.","DOI":"10.1016\/S0002-9149(96)00675-3"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/qjmed\/article-pdf\/97\/3\/179\/12858654\/hch033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T23:45:09Z","timestamp":1585611909000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article-lookup\/doi\/10.1093\/qjmed\/hch033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2004,3]]},"published-print":{"date-parts":[[2004,3]]}},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hch033","relation":{},"ISSN":["1460-2393","1460-2725"],"issn-type":[{"value":"1460-2393","type":"electronic"},{"value":"1460-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}